More than ever, people are in pursuit of greater fulfillment in their lives, seeking a deeper spiritual truth and strategies for liberation from suffering. Both Buddhism and psychedelics are inevitable subjects encountered on the journey to wisdom. Examined together, the reader may understand more deeply the essence of each.
Changing Our Minds is an experiential tour through a social, spiritual and scientific revolution that is redefining our culture’s often confusing relationship with psychoactive substances. Veteran journalist Don Lattin chronicles the inspiring stories of pioneering neuroscientists, psychotherapists, spiritual leaders and ordinary people seeking to lead healthier lives by combining psychedelic drugs, psychotherapy, and the wise use of ancient plant medicine.
Internationally respected Peruvian shaman Don José Campos introduces the practices and benefits of Ayahuasca, the psychoactive plant brew that, according to the latest finds, has been used for healing by Amazonian shamans for as long as 70,000 years. Ayahuasca is called a plant teacher because it can heal physical, psychological, and emotional blocks. Through vivid visions, Ayahuasca takes the patient to other realms and dimensions, providing profound insights into human beings’ true nature and place in the cosmos. This book also includes the last interview (and the artwork) of internationally renowned visionary painter and former shaman Pablo Amaringo.
Leary recounts his extraordinary life and encounters with such diverse figures as Aldous Huxley, Ram Dass, Jack Keronac, Eldridge Cleaver, and Charles Manson.
Psychedelic Psychotherapy is a comprehensive, easy-to-read resource for therapists and laypeople who need practical guidelines for psychedelic drug-assisted psychotherapy. This book contains valuable insiders’ information for those using psychedelics for their own healing, and for practitioners who facilitate their sessions with a focus of healing trauma using MDMA, LSD, and psilocybin.
A conversational memoir by pioneers of consciousness research, Ram Dass and Ralph Metzner.
The story of two generations of scientific explorers in South America—Richard Evans Schultes and his protégé Wade Davis—an epic tale of adventure and a compelling work of natural history.
In 1941, Professor Richard Evan Schultes took a leave from Harvard and disappeared into the Amazon, where he spent the next twelve years mapping uncharted rivers and living among dozens of Indian tribes. In the 1970s, he sent two prize students, Tim Plowman and Wade Davis, to follow in his footsteps and unveil the botanical secrets of coca, the notorious source of cocaine, a sacred plant known to the Inca as the Divine Leaf of Immortality.
A stunning account of adventure and discovery, betrayal and destruction, One River is a story of two generations of explorers drawn together by the transcendent knowledge of Indian peoples, the visionary realms of the shaman, and the extraordinary plants that sustain all life in a forest that once stood immense and inviolable.
Fadiman reviews the newest as well as the neglected research into the psychotherapeutic value of visionary drug use for increased personal awareness and a host of serious medical conditions, including his recent study of the reasons for and results of psychedelic use among hundreds of students and professionals. He reveals new uses for LSD and other psychedelics, including microdosing, extremely low doses for improved cognitive functioning and emotional balance. Cautioning that psychedelics are not for everyone, he dispels the myths and misperceptions about psychedelics circulating in textbooks and clinics as well as on the internet. Exploring the life-changing experiences of Ram Dass, Timothy Leary, Aldous Huxley, and Huston Smith as well as Francis Crick and Steve Jobs, Fadiman shows how psychedelics, used wisely, can lead not only to healing but also to scientific breakthroughs and spiritual epiphanies.
Since the discovery of its psychedelic properties in 1943, lysergic acid diethylamide (LSD) has been explored by psychiatric/therapeutic researchers, military/intelligence agencies, and a significant portion of the general population. Promising early research was halted by LSD’s placement as a Schedule I drug in the early 1970s. The U.S. Army and CIA dropped their research after finding it unreliable for their purposes. NSDUH estimates that more than 22 million (9.1% of the population) have used LSD at least once in their lives. Recently, researchers have been investigating the therapeutic use of LSD and other psychedelics for end-of-life anxiety, post-traumatic stress disorder (PTSD), cancer, and addiction treatment. Adverse psychedelic reactions can be managed using talkdown techniques developed and in use since the 1960s.
A New Understanding explores the treatment of end-of-life anxiety in terminally ill cancer patients using psilocybin, a psychoactive compound found in some mushrooms, to facilitate deeply spiritual experiences. The documentary explores the confluence of science and spirituality in the first psychedelic research studies since the 1970s with terminally ill patients. As a society we devote a great deal of attention to treating cancer, but very little to treating the human being who is dying of cancer.